Health Care · Pharmaceutical Preparations · OTC · CIK 1583771 · FYE Dec 31 · Prices AT CLOSE 2026-08-20 (USD) Last $0.06 · Day +0.00% · Mkt cap $6M · 1Y +17.3% · Off 52W high −45.3% · Vol (1Y) 264.1% Price2023-08-21 → 2026-08-20 HEPA close: $363 on 2023-08-21 to $0 on 2026-08-20. Split-adj closes · 240 of 3,149 · price returnⓘ At a glance | Short interest0.0% of sh out | | Days to cover1.0d | | Next report (est.)2026-11-11 |
SI 2026-07-31ⓘ Key fundamentalsFY 2025 | Sales (TTM)$0 | | Earnings (TTM)-$3.2M |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+1.7% | | 1Y+17.3% | | 3Y−100.0% | | 5Y−100.0% | | 10Y−100.0% | | Since incept. (ann.)−62.9% |
Total return · from 2014-02-11ⓘ Risk | Ann. volatility (1Y)264.1% | | Ann. volatility (3Y)198.4% | | Sharpe (1Y)1.24 | | Sharpe (3Y)−0.48 | | Max drawdown (1Y)−61.4% | | Max drawdown (3Y)−100.0% | | Beta (3Y vs SPY)1.88 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 No 13F holders on file for HEPA. Latest reported quarterslast report 2026-08-13 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-13 | −$0.08 | — | — | — | | 2026-03-31 | 2026-05-14 | −$0.07 | — | — | — | | 2025-09-30 | 2025-11-12 | −$0.04 | — | — | — | | 2025-06-30 | 2025-08-14 | −$0.09 | — | — | — |
As-reported XBRL · next 2026-11-11 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
